60KRW
1.99 BKRW
12.62 BKRW
41.92 M
About NEWGLAB PHARMA
Sector
Industry
CEO
Dae-Woo Park
Website
Headquarters
Bucheon-si
Employees (FY)
15
Founded
2004
ISIN
KR7214870008
FIGI
BBG009XY3KQ3
NewGLAB Pharma Co., Ltd. engages in the manufacture of closed-circuit television camera and equipment. Its products include high definition multimedia interface, camera, analog camera, accessories, modules, digital and network video record, and others. The company was founded on February 24, 2004 and is headquartered in Bucheon-si, South Korea.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of 214870 is 1383 KRW — it has decreased by 27.44% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on KRX exchange NEWGLAB PHARMA stocks are traded under the ticker 214870.
214870 stock is 45.72% volatile and has beta coefficient of 1.57. Check out the list of the most volatile stocks — is NEWGLAB PHARMA there?
Yes, you can track NEWGLAB PHARMA financials in yearly and quarterly reports right on TradingView.
214870 net income for the last quarter is 7.44 B KRW, while the quarter before that showed 10.36 B KRW of net income which accounts for −28.24% change. Track more NEWGLAB PHARMA financial stats to get the full picture.
No, 214870 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, 214870 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade NEWGLAB PHARMA stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 18, 2024, the company has 15.00 employees. See our rating of the largest employees — is NEWGLAB PHARMA on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So NEWGLAB PHARMA technincal analysis shows the sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating NEWGLAB PHARMA stock shows the strong sell signal. See more of NEWGLAB PHARMA technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. NEWGLAB PHARMA EBITDA is 6.20 B KRW, and current EBITDA margin is 48.24%. See more stats in NEWGLAB PHARMA financial statements.